Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Wincanton profit down; James Cropper ups payout

Thu, 09th Nov 2023 12:54

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Wincanton PLC - Wiltshire, England-based logistics firm - Revenue in half-year ended September 30 down 7.8% on-year to GBP694.7 million from GBP753.6 million 12 months earlier. Pretax profit falls 26% to GBP19.1 million from GBP25.8 million. Wincanton maintains its interim dividend at 4.4 pence per share. The firm says: "[The] 7.8% revenue reduction from prior year reflecting the group's strategic shift out of closed book transport contracts and towards digitally enabled 4PL solutions." It believes it can achieve revenue and profit in line with market expectations for the full-year.

----------

James Cropper PLC - Cumbria, England-based paper, packaging and advanced materials manufacturer - Revenue in half-year ended September 30 declines 8.3% on-year to GBP56.5 million from GBP61.6 million. Swings to pretax profit of GBP2.4 million from GBP900,000 loss, however. James Cropper ups its interim dividend to 3.0 pence from 2.0p. Chief Executive Officer Steve Adams says: "We have achieved a healthy first half performance with benefits from our accelerated growth strategy now becoming evident, following considerable hard work and commitment by the James Cropper team. In spite of ongoing wider macro-economic pressures and softer demand across paper, the actions taken to streamline the business and focus on higher margin opportunities have helped deliver an improvement in profitability. Advanced Materials continues to perform well with Future Energy again exceeding expectations."

----------

Fusion Antibodies PLC - Belfast-based contract research organisation providing discovery, design and optimisation services for therapeutic antibodies to the healthcare market - Cautions that an easing of constraints in the first half ended September 30 "has not materialised as quickly as expected". Fusion adds: "Consequently, trading conditions remain very challenging and revenue for H1 FY2024 is expected to be behind current market expectations, at not less than GBP541,000. Towards the end of the period, several projects were subject to certain technical challenges which required additional work to be undertaken, thereby pushing some of the expected H1 recognised revenue into H2. The remainder of the shortfall was due to a delayed project initiation. Nevertheless, the Company has achieved a marked growth in the sales pipeline with overall values now standing at approximately four times that of six months ago." Says lower-than-expected first-half outturn has been offset by cost control, so its cash runway expectations are unchanged.

----------

Chill Brands Group PLC - Colorado, US-based CBD products company - Says its Chill ZERO nicotine-free vapour products will launch on Vape Local this month. "Vape Local is one of the UK's leading wholesale websites for vaping products, serving a rapidly growing network of over 4,000 retail store accounts. In joining the site, Chill ZERO nicotine-free products will gain exposure to thousands of potential stockists spread across the entirety of the country," it adds.

----------

Vinanz Ltd - British Virgin Islands-registered bitcoin mining company - Raises GBP350,000 at 3.0 pence per share, a 4.4% premium to its Wednesday closing price of 2.88p. Funds will be used to acquire 250 additional bitcoin miners which will "approximately triple the company's current bitcoin mining fleet in North America".

----------

PPHE Hotel Group Ltd - London-based hotel and resort operator - Plots March 2024 open for premium lifestyle flagship art'otel London Hoxton. "The opening follows the art'otel brand's successful London debut at Battersea Power Station in February 2023, and in Zagreb in October 2023. art'otel Rome is set to open in H1 2024, further illustrating the significant opportunity within the group's GBP300+ million development pipeline," PPHE says.

----------

Nightcap PLC - London-based owner of Cocktail Club, Adventure Bar and Barrio Familia chains - Says eight of 10 Dirty Martini existing leases have been assigned to company. One lease previously operated by DC Bars Ltd has not. This is in Hanover Square, London, after the landlord did not agree to reduce rental costs to "make the site profitable". Nightcap adds: "The company has entered into a new three year lease for the Tuttons restaurant and Dirty Martini Covent Garden site. This lease covers a restaurant lease as well as the small downstairs cocktail bar. The new lease is on considerably more favourable commercial terms and is in line with Nightcap's objective to not remain as a restaurant operator in the long term." Nightcap added the Dirty Martini brand to its portfolio in June after buying both DC Bars and Tuttons Brasserie Ltd for up to GBP4.7 million.

----------

Knights Group Holdings PLC - Newcastle-under-Lyme, Staffordshire-based legal and professional services firm - Agrees new extended revolving credit facility with HSBC UK, Allied Irish Bank (GB) and NatWest. Facility provides total committed funding of GBP70 million until November 2025. Knights says the loan gives it "headroom and flexibility to continue to execute our strategy".

----------

European Metals Holdings Ltd - Czechia-focused mineral exploration and development company - Says pilot programme has "confirmed industrial viability" for lithium chemical plant process flowsheet at Cinovec project. Says "exceptionally clean battery grade lithium carbonate produced". "Work to produce battery grade lithium hydroxide monohydrate is underway," the firm adds. Cadence Minerals PLC, a 5.6% shareholder in EMH, notes the announcement.

----------

Genel Energy PLC - Kurdistan-focused oil and gas exploration and production company - Says DNO ASA, operator of Tawke asset which Genel has a 25% working interest in, says field has gradually reopened and deliveries to local trading companies in Kurdistan region of Iraq have "stepped-up". The update comes after the Iraq-Turkey oil pipeline was closed in March. "The Tawke field was reopened on 18 July, and gross production from the Tawke licence in Q3 2023 totalled 25,984 barrels of oil per day. Production continues to increase; so far in the fourth quarter output is averaging double the level of the third quarter, with the Peshkabir field having restarted production on 16 October," Genel says.

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
30 Mar 2020 16:52

Fusion Antibodies Trading In Line With Expectations Amid Outbreak

Fusion Antibodies Trading In Line With Expectations Amid Outbreak

Read more
17 Mar 2020 15:54

DIRECTOR DEALINGS SUMMARY: IWG And Man Chiefs Buy GBP3 Million Worth

DIRECTOR DEALINGS SUMMARY: IWG And Man Chiefs Buy GBP3 Million Worth

Read more
3 Feb 2020 17:32

DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth

DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Boss Buys GBP200,000 Worth

Read more
29 Jan 2020 13:35

Fusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations

Fusion Antibodies Expects Annual Revenue Rise Ahead Of Expectations

Read more
29 Jan 2020 09:32

Fusion Antibodies sees 'favourable trends' continue in H2

(Sharecast News) - Pre-clinical therapeutic drug and diagnostics firm Fusion Antibodies said on Wednesday that trading in the third quarter of the financial year had continued the "favourable trends" experienced in the first half.

Read more
10 Jan 2020 12:09

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares

DIRECTOR DEALINGS: Fusion Antibodies Non-Executive Mawson Buys Shares

Read more
3 Dec 2019 18:08

DIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares

DIRECTOR DEALINGS: Fusion Antibodies Non-Exec Mawson Buys Shares

Read more
2 Dec 2019 11:27

Fusion Antibodies cuts losses after revenue leaps

(Sharecast News) - Fusion Antibodies on Monday reported a narrowed loss after revenue more than doubled following the launch of its RAMP service.

Read more
2 Dec 2019 10:49

Fusion Antibodies Revenue Takes Off But Order Visibility Cloudy

Fusion Antibodies Revenue Takes Off But Order Visibility Cloudy

Read more
22 Oct 2019 15:13

Fusion Antibodies pleased with progress in first half

(Sharecast News) - Preclinical antibody discovery company Fusion Antibodies updated the market on the six months ended 30 September on Tuesday, reporting continued revenue growth amid the commercial roll out of new services.

Read more
22 Oct 2019 14:31

Fusion Antibodies Predicts Rise In Interim Revenue And Orders

Fusion Antibodies Predicts Rise In Interim Revenue And Orders

Read more
3 Jul 2019 17:03

DIRECTOR DEALINGS: Fusion Antibodies CEO, Non-Executives Buy Shares

(Alliance News) - Fusion Antibodies PLC said Wednesday that its Chief Executive Officer and two Non-Executive Directors have bought around GBP31,794 in shares in the company in deals on Executive

Read more
2 Jul 2019 10:46

Fusion Antibodies Annual Loss Widens After Rocky First Half

(Alliance News) - Fusion Antibodies PLC on Tuesday said its loss gapped wider after a weak first half brought annual revenue down 19%, though this was followed by a much stronger second antibody a

Read more
17 Apr 2019 11:49

Fusion Antibodies Annual Revenue Declines On Weak First Half

LONDON (Alliance News) - Fusion Antibodies PLC on Wednesday reported an improved performance in the second half of its recently ended financial year after "disappointing" first company a

Read more
17 Apr 2019 10:46

Fusion Antibodies revenues soar in strong second half

(Sharecast News) - Pharmaceutical research outfit Fusion Antibodies reported a strong second half on Wednesday, driven by a significant increase in orders.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.